Eczematous drug eruption (Q91670): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 18:42, 15 August 2026
Drug eruptions are rarely eczematous in nature and a diagnosis of eczematous drug eruption should be made only when there is convincing evidence that the eczema is related to drug exposure. They may occur as a result of prior topical sensitization to an allergen contained in or which cross reacts with a compound present in a medication administered systemically (systemic allergic contact dermatitis).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_715259533 |
||
| English | Eczematous drug eruption |
Drug eruptions are rarely eczematous in nature and a diagnosis of eczematous drug eruption should be made only when there is convincing evidence that the eczema is related to drug exposure. They may occur as a result of prior topical sensitization to an allergen contained in or which cross reacts with a compound present in a medication administered systemically (systemic allergic contact dermatitis). |
Statements
CID11:ID_715259533
0 references
dki-india-ID_715259533
0 references
Concluído
0 references
13 August 2026
0 references
